Compound prescription drug coverage; health insurance plan providing prescription drug coverage; effective date.
Impact
The amendment is expected to require health insurance plans to allow pharmacies to bid periodically for contracts to provide compounded drugs, promoting competitiveness in the pharmacy sector. This can potentially lead to more options for consumers and possibly lower costs. It also establishes a framework for ensuring that compound prescription drugs are treated similarly to regular prescription drugs within health insurance plans, thereby impacting how pharmacy benefits are administered.
Summary
House Bill 3368 seeks to amend Section 3634.3 of the Oklahoma Statutes regarding prescription drug coverage under health insurance plans. The primary aim of this legislation is to ensure that health insurance plans and health maintenance organizations (HMOs) cover compound prescription drugs as part of their pharmacy services. By including compound prescriptions, the bill addresses a gap that can affect patients' access to these essential medications, which are often necessary for unique medical needs.
Contention
The bill might raise concerns among stakeholders about the extent of coverage and how it will be implemented across various insurance providers. While proponents argue that this will enhance patient care and accessibility to compounded medications, critics may voice concerns about the implications for costs to insurers and possible implications for managing pharmacy benefits efficiently. Additionally, there could be debates on the balance between providing necessary medications and ensuring that quality controls are maintained in the dispensing of compound prescriptions.
Prescriptions; creating the Oklahoma Health Care Safety Net and Affordable Prescriptions Acessibility Act; prohibiting certain actions; providing for enforcement by Attorney General and Insurance Commissioner. Effective date.
Prescription drugs; creating the Access to Lifesaving Medicines Act; prohibiting certain costs and requiring rebates under certain plans. Effective date.
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.